Difference between revisions of "Niedzwiecki D, et al. J. Clin. Oncol. (2011) cited as Ref 563 in DOI: 10.1038/s41392-020-0110-5 (Q9826)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 29, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581, #quic...) |
||
| Property / title | |||
| + | Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581 (English) | ||
| Property / title: Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581 (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Niedzwiecki D, et al. J. Clin. Oncol. (2011) cited as Ref 563 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Niedzwiecki D
0 references
2011
0 references
J. Clin. Oncol.
0 references
29
0 references
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581 (English)
0 references
